Complement Receptor 1 Enhancement in Recurrent Membranous Nephropathy Following Kidney Transplantation: A Case Report

Noriyuki Kounoue1,2, Hideyo Oguchi1, Akinori Hashiguchi3

  • 1Department of Nephrology, Toho University Faculty of Medicine, Tokyo, Japan.

Kidney Medicine
|September 9, 2024
PubMed

Insights

Recurrent membranous nephropathy (MN) in kidney transplants was observed. Complement receptor 1 (CR1) was found to be elevated and colocalized with IgG in glomerular capillaries, suggesting CR1 as a potential antigen in this unique MN case.

Area of Science:

  • Nephrology
  • Immunology
  • Transplantation

Background:

  • Membranous nephropathy (MN) recurrence post-kidney transplant leads to increased graft failure.
  • Identifying the cause of recurrent MN is crucial for improving patient outcomes.

Observation:

  • A unique case of recurrent MN in a patient's first and second kidney allografts is presented.
  • Glomerular capillary walls showed positivity for complement receptor 1 (CR1) and immunoglobulin G (IgG).
  • Standard markers like IgG4 and phospholipase A2 receptor (PLA2R) were negative.

Findings:

  • Mass spectrometry revealed increased CR1 levels in transplanted kidney biopsies.
  • Immunohistochemistry and immunofluorescence showed CR1 colocalized with IgG along glomerular capillaries.
  • Electron microscopy localized CR1 at the interface between electron-dense deposits and podocytes.

Implications:

  • This case highlights a novel finding of CR1 enhancement and specific localization in recurrent MN.
  • CR1 is proposed as a potential causative antigen in this form of MN.
  • Further research is needed to elucidate the pathogenesis of CR1-associated MN.